Related Experiment Video
Updated: Jul 18, 2026

11:49
Single-port Non-liposuction Endoscopic Axillary Lymph Node Dissection in Breast Cancer Surgery
Published on: April 3, 2026
[Should we resect all premalignant breast lesions?]
Jean-François Delaloye1, Hans-Anton Lehr
1Département de gynécologie-obstétrique,Pr Hans-Anton Lehr, Institut universitaire de pathologie, CHUV, 1011 Lausanne.
Revue Medicale Suisse
|November 24, 2006
Abstract:
Premalignant breast lesions are defined by their characteristic histologic features. Based on these criteria, an increased risk is assigned of eventually progressing towards a malignant lesion, but the most majority of these lesions will never progress to cancer. Hence, the clinical management depends on correct sampling and thorough histologic examination.
